Mecamylamine
Back to searchMolecule Structure
Scientific Name
Mecamylamine
Description of the Drug
Mecamylamine is a nicotine antagonist used to treat moderate to severe essential hypertension and uncomplicated malignant hypertension.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00657
http://www.drugbank.ca/drugs/DB00657
Brand Name(s)
Not Available
Company Owner(s)
Lgm Pharma Solutions Llc, Targacept Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Neuronal acetylcholine receptor; alpha3/beta4 | PROTEIN COMPLEX | NEGATIVE ALLOSTERIC MODULATOR | CHEMBL1907594 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL34252 | |
PharmGKB | PA450334 | |
Human Metabolome Database | HMDB0014795 | |
DrugBank | DB00657 | |
PubChem: Thomson Pharma | 14748127 | |
PubChem | 4032 | |
NMRShiftDB | 70008387 | |
LINCS | LSM-4990 | |
Nikkaji | J4.802J | |
BindingDB | 50061565 | |
EPA CompTox Dashboard | DTXSID0023240 | |
DrugCentral | 1646 | |
Brenda | 147739 | |
Guide to Pharmacology | 3990 | |
rxnorm | MECAMYLAMINE | MECAMYLAMINE HYDROCHLORIDE |
KEGG Ligand | C07511 | |
ChEBI | 6706 |